Neumora Therapeutics, Inc. Common Stock (NMRA)
USD 0.78
(0.62%)
USD 0.78
(0.62%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -368.8 Million USD | -58.63% |
| 2022 | -232.5 Million USD | 42.9% |
| 2021 | -407.19 Million USD | -114.39% |
| 2020 | -189.93 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -147.07 Million USD | 17.61% |
| 2024 Q1 | -178.49 Million USD | 51.6% |
| 2023 Q1 | -203.23 Million USD | 12.59% |
| 2023 FY | -368.8 Million USD | -58.63% |
| 2023 Q3 | -406.14 Million USD | -105.75% |
| 2023 Q2 | -197.39 Million USD | 2.87% |
| 2023 Q4 | -368.8 Million USD | 9.19% |
| 2022 Q1 | -289.41 Million USD | 28.92% |
| 2022 Q4 | -232.5 Million USD | 0.0% |
| 2022 FY | -232.5 Million USD | 42.9% |
| 2022 Q2 | -167.02 Million USD | 42.29% |
| 2021 Q4 | -407.19 Million USD | 6.73% |
| 2021 FY | -407.19 Million USD | -114.39% |
| 2021 Q3 | -436.59 Million USD | 0.0% |
| 2020 Q4 | -189.93 Million USD | 0.0% |
| 2020 FY | -189.93 Million USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Absci Corporation | -72.59 Million USD | -408.013% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 324.379% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 119.723% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -489462.482% |
| Apollomics, Inc. | -27.39 Million USD | -1246.257% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -56143.728% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -316.92% |
| Bicycle Therapeutics plc | -481.46 Million USD | 23.399% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -185.644% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 1119.846% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 8974.086% |
| Chimerix, Inc. | -25.51 Million USD | -1345.338% |
| CRISPR Therapeutics AG | -150.84 Million USD | -144.494% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 307.584% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -33.726% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4911.572% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4911.572% |
| Gritstone bio, Inc. | 39.49 Million USD | 1033.925% |
| Allakos Inc. | -24.97 Million USD | -1376.705% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1614.504% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3990.583% |
| Cytokinetics, Incorporated | 642.37 Million USD | 157.413% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -414.067% |
| Innoviva, Inc. | 255.56 Million USD | 244.312% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3892.633% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 50205.154% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -809.019% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -6473.787% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -364.943% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -866.931% |
| ImmuCell Corporation | 10.99 Million USD | 3455.67% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -139.258% |
| Incyte Corporation | -3.17 Billion USD | 88.384% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 2419.777% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -30940.833% |
| Mustang Bio, Inc. | -3.73 Million USD | -9771.708% |
| MiMedx Group, Inc. | -33.9 Million USD | -987.894% |
| MEI Pharma, Inc. | -3.7 Million USD | -9854.305% |
| MacroGenics, Inc. | -66.98 Million USD | -450.581% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -4975.735% |
| Mereo BioPharma Group plc | -51.46 Million USD | -616.561% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -2340.58% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -3510.799% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 1124.322% |
| Minerva Neurosciences, Inc. | 41 Million USD | 999.436% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1558.902% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -14431.403% |
| NextCure, Inc. | -6.47 Million USD | -5594.102% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -1177.386% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -630.296% |
| Onconetix, Inc. | 5.33 Million USD | 7017.591% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -5681.58% |
| Opthea Limited | 28.15 Million USD | 1409.803% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 2045.163% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 5449.217% |
| PDS Biotechnology Corporation | -32.7 Million USD | -1027.543% |
| Precigen, Inc. | -481 Thousand USD | -76575.052% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -2020.068% |
| Prime Medicine, Inc. | -27.94 Million USD | -1219.949% |
| PureTech Health plc | -167.19 Million USD | -120.582% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -1095.02% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1260.911% |
| Replimune Group, Inc. | 1.41 Million USD | 26219.476% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2975.519% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1426.978% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -15817.251% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 39.361% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1891.414% |
| Sesen Bio, Inc. | -112.55 Million USD | -227.674% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -5094.465% |
| Solid Biosciences Inc. | -47.75 Million USD | -672.371% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -25.547% |
| SciSparc Ltd. | -2.06 Million USD | -17759.903% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 424.994% |
| TG Therapeutics, Inc. | 17.86 Million USD | 2164.758% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -2336.782% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -5840.834% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 206.405% |
| UroGen Pharma Ltd. | 4.39 Million USD | 8499.157% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1434.33% |
| XOMA Corporation | -29 Million USD | -1171.748% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 2179.543% |
| AbCellera Biologics Inc. | -55.94 Million USD | -559.29% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2561.713% |
| Cassava Sciences, Inc. | -121.13 Million USD | -204.457% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 5392.81% |
| Precision BioSciences, Inc. | -85.41 Million USD | -331.808% |
| Dyadic International, Inc. | -6.37 Million USD | -5682.397% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -4291.605% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -2214.737% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -1110.791% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -1008.961% |
| IGM Biosciences, Inc. | -72.6 Million USD | -407.957% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -795.489% |
| Acelyrin, Inc. | -216.9 Million USD | -70.033% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3964.885% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -2096.718% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -4216.978% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -16.42% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -376.181% |
| Senti Biosciences, Inc. | 1.74 Million USD | 21295.805% |
| Mesoblast Limited | 55.96 Million USD | 759.019% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1358.196% |
| ChromaDex Corporation | -24.04 Million USD | -1433.629% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -42680.618% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 702.065% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -4858.326% |
| Seer, Inc. | -4.24 Million USD | -8598.278% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 328.022% |
| Novavax, Inc. | -298.29 Million USD | -23.639% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3934.42% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 698.072% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -7383.908% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -347.147% |
| Celcuity Inc. | 6.78 Million USD | 5536.817% |
| ContextLogic Inc. | -232 Million USD | -58.969% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -52.171% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -233.65% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 108.034% |
| Amarin Corporation plc | -191.04 Million USD | -93.052% |
| AnaptysBio, Inc. | -18.15 Million USD | -1931.883% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -3105.066% |
| Aptorum Group Limited | 1.35 Million USD | 27277.192% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -459.171% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 8716.986% |
| Ardelyx, Inc. | 34.51 Million USD | 1168.634% |
| Celularity Inc. | 65.19 Million USD | 665.742% |
| Omeros Corporation | 331.17 Million USD | 211.363% |
| Humacyte, Inc. | -22.48 Million USD | -1540.163% |
| Immunocore Holdings plc | -358.59 Million USD | -2.848% |
| IO Biotech, Inc. | -140.69 Million USD | -162.125% |
| GT Biopharma, Inc. | -1.02 Million USD | -36022.135% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -95.945% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1163.641% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -5983.916% |
| Pulmatrix, Inc. | -10.41 Million USD | -3440.434% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -231.06% |
| Evogene Ltd. | -19.63 Million USD | -1778.41% |
| CorMedix Inc. | -43.05 Million USD | -756.645% |
| BioLineRx Ltd. | 7.33 Million USD | 5127.358% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -215.096% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -391.258% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -106.066% |
| scPharmaceuticals Inc. | -6.54 Million USD | -5534.943% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -2401.743% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -172.383% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 50205.154% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1891.414% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -77.171% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -297.58% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1554.733% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -99.78% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1283.424% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 3132.138% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -2109.462% |
| Daré Bioscience, Inc. | -5.15 Million USD | -7050.317% |
| bluebird bio, Inc. | 108.57 Million USD | 439.692% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 197.375% |
| DBV Technologies S.A. | -126.98 Million USD | -190.431% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -110.47% |
| Galecto, Inc. | -21.21 Million USD | -1638.344% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -5321.241% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -302.057% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -444.1% |
| GlycoMimetics, Inc. | -40.98 Million USD | -799.871% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 416.32% |
| ADMA Biologics, Inc. | 90.06 Million USD | 509.485% |
| Clene Inc. | 3.34 Million USD | 11142.126% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -7.173% |
| Aptose Biosciences Inc. | -8.19 Million USD | -4400.469% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -11686.669% |
| Soligenix, Inc. | -4.95 Million USD | -7348.243% |
| Century Therapeutics, Inc. | 847 Thousand USD | 43642.739% |
| Kura Oncology, Inc. | -20.11 Million USD | -1733.219% |
| Surrozen, Inc. | -32.66 Million USD | -1029.093% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -801.156% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 20345.266% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -11436.034% |
| Autolus Therapeutics plc | -186.59 Million USD | -97.647% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -648.027% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1176.243% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1457.659% |
| GRI Bio, Inc. | -1.79 Million USD | -20457.804% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -4005.59% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 7010.38% |
| INmune Bio, Inc. | -25.41 Million USD | -1351.368% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 344.322% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -628.019% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2169.669% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3869.411% |
| Jaguar Health, Inc. | 29.39 Million USD | 1354.83% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -12683.933% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 1070.162% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2719.182% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1256.679% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 197.581% |
| Verastem, Inc. | -37.27 Million USD | -889.342% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -611.131% |
| Histogen Inc. | -7.48 Million USD | -4825.965% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1606.901% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -180.564% |
| Surrozen, Inc. | -32.66 Million USD | -1029.093% |
| Organovo Holdings, Inc. | -1.5 Million USD | -24372.926% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8673.833% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -4300.434% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -748.964% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -2430.085% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -50977.057% |
| Kronos Bio, Inc. | -36.05 Million USD | -922.93% |
| Turnstone Biologics Corp. | -14.58 Million USD | -2428.847% |
| Synaptogenix, Inc. | -28.66 Million USD | -1186.768% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -39302.457% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 58827.229% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 856.807% |
| Exelixis, Inc. | -73.05 Million USD | -404.869% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1435.864% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -52.797% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -338.529% |
| ESSA Pharma Inc. | -33.62 Million USD | -996.935% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -13911.679% |
| Avid Bioservices, Inc. | 169.72 Million USD | 317.293% |
| Insmed Incorporated | 721.62 Million USD | 151.108% |
| MediWound Ltd. | -5.32 Million USD | -6829.857% |
| OmniAb, Inc. | 9.2 Million USD | 4107.465% |
| Alector, Inc. | -35.63 Million USD | -934.899% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 528.99% |
| Zai Lab Limited | -775 Million USD | 52.412% |
| AlloVir, Inc. | -62.69 Million USD | -488.284% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 208.296% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2700.144% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1613.389% |
| Immunic, Inc. | -45.34 Million USD | -713.425% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -90.879% |
| Veracyte, Inc. | -203.82 Million USD | -80.944% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 157.78% |
| FibroGen, Inc. | 56.76 Million USD | 749.686% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4241.572% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -175.067% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -12945.501% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -17713.769% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -10938.821% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -122.221% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 123.5% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1407.057% |
| XBiotech Inc. | -200.02 Million USD | -84.382% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -338.529% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -16.452% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -21292.517% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 8245.031% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -945.875% |
| Agenus Inc. | 274.13 Million USD | 234.534% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -377.618% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 6580.531% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -116.417% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -299.254% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 150.092% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -3325.171% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -563.155% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -10581.782% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -4008.788% |
| Lantern Pharma Inc. | -21.7 Million USD | -1599.315% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -8620.903% |
| Ainos, Inc. | 4.07 Million USD | 9143.98% |
| Pluri Inc. | 22.82 Million USD | 1715.52% |
| Prothena Corporation plc | -608.34 Million USD | 39.376% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -210.559% |
| Rallybio Corporation | -24.1 Million USD | -1430.193% |
| Kodiak Sciences Inc. | -103.87 Million USD | -255.049% |
| Cue Biopharma, Inc. | -33.81 Million USD | -990.532% |
| MeiraGTx Holdings plc | -40.3 Million USD | -815.108% |
| Annexon, Inc. | -193.75 Million USD | -90.347% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -2007.589% |
| Moderna, Inc. | -2.9 Billion USD | 87.313% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1400.741% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -1093.512% |
| Blueprint Medicines Corporation | 702.83 Million USD | 152.474% |
| Immix Biopharma, Inc. | -17.5 Million USD | -2006.29% |
| CalciMedica, Inc. | -5.53 Million USD | -6569.204% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -349.425% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -821.165% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -119.224% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -1009.094% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -6070.437% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -515.252% |
| Nutriband Inc. | -251.65 Thousand USD | -146451.457% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -980.943% |
| Vor Biopharma Inc. | 4.3 Million USD | 8676.907% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 93.89% |
| Alkermes plc | -166.73 Million USD | -121.188% |
| ProKidney Corp. | -56.23 Million USD | -555.82% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -657.74% |
| Arcellx, Inc. | -296.95 Million USD | -24.195% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 127.041% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -1242.825% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 899.2% |
| Atai Life Sciences N.V. | -28.55 Million USD | -1191.431% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 16634.508% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1516.44% |
| MediciNova, Inc. | -50.78 Million USD | -626.234% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -367.999% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1639406.557% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5615.644% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -84.569% |
| Biomea Fusion, Inc. | -166.57 Million USD | -121.413% |
| RenovoRx, Inc. | -1.17 Million USD | -31341.347% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -288.856% |
| Geron Corporation | 14.76 Million USD | 2598.523% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 8177.245% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -57.316% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -291.469% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -285.394% |
| Royalty Pharma plc | 5.65 Billion USD | 106.518% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -843.892% |
| Imunon, Inc. | -4.21 Million USD | -8652.253% |
| BioAtla, Inc. | -109.01 Million USD | -238.321% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 3182.124% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1639.41% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -162.065% |
| Structure Therapeutics Inc. | -124.33 Million USD | -196.614% |
| 89bio, Inc. | -289.05 Million USD | -27.591% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -2127.095% |
| aTyr Pharma, Inc. | -7.44 Million USD | -4851.094% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -195.907% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -350.98% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -42825.264% |
| Akari Therapeutics, Plc | -3.84 Million USD | -9491.86% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 22825.323% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 126.708% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 541.162% |
| Liquidia Corporation | -80.17 Million USD | -359.997% |
| Entera Bio Ltd. | -10.62 Million USD | -3369.818% |
| GH Research PLC | -78.07 Million USD | -372.363% |
| Vericel Corporation | 1.27 Million USD | 28980.736% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1999.789% |
| Xencor, Inc. | 29.64 Million USD | 1344.12% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -18622.954% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2169.669% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -150490.017% |
| Vaxcyte, Inc. | -368.22 Million USD | -0.158% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -167.756% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -191.738% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -30940.833% |
| Portage Biotech Inc. | -4.98 Million USD | -7304.276% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1639406.557% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -457.767% |
| OncoCyte Corporation | -6.56 Million USD | -5519.488% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 41196.686% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -7995.608% |
| Purple Biotech Ltd. | -14.13 Million USD | -2508.622% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1886.144% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -6193.635% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -526.999% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1452.479% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1505.184% |
| United Therapeutics Corporation | -507.7 Million USD | 27.357% |
| HilleVax, Inc. | -165.48 Million USD | -122.864% |
| Silo Pharma, Inc. | -3.52 Million USD | -10364.664% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 369760.917% |
| Pharming Group N.V. | 109.8 Million USD | 435.878% |
| Tharimmune, Inc. | -10.93 Million USD | -3272.612% |
| Genprex, Inc. | -6.73 Million USD | -5373.84% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -217.166% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 3717.528% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -26224.554% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -11018.873% |
| OKYO Pharma Limited | -826.84 Thousand USD | -44503.966% |
| Savara Inc. | 153 Thousand USD | 241150.327% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 3047.862% |
| Curis, Inc. | -23.88 Million USD | -1443.965% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -47425.94% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 31222.954% |
| BeiGene, Ltd. | -2.25 Billion USD | 83.631% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -98.726% |
| Erasca, Inc. | -37.21 Million USD | -890.99% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -28536.463% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -28536.463% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -3462.664% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -3293.513% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -1075.63% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -1042.808% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -972.862% |
| Adicet Bio, Inc. | -138.78 Million USD | -165.736% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 286.205% |
| Aditxt, Inc. | 18.12 Million USD | 2135.259% |
| Adagene Inc. | -87.62 Million USD | -320.881% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8754.0% |
| Quantum-Si incorporated | -118.55 Million USD | -211.08% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -4834.409% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -660.286% |
| Compugen Ltd. | -12.9 Million USD | -2758.083% |
| Generation Bio Co. | 31.44 Million USD | 1272.752% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -110.309% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -1092.662% |
| Invivyd, Inc. | -198.47 Million USD | -85.819% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -308.56% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -15281.774% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -420.987% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -5303.766% |
| 2seventy bio, Inc. | 181.71 Million USD | 302.959% |
| Instil Bio, Inc. | 75.35 Million USD | 589.407% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3960.542% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -11734.537% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5615.644% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1318.506% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -8913.833% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -6980.188% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -183.036% |
| Evaxion Biotech A/S | 5.28 Million USD | 7075.939% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -227.63% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -180.947% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -615.991% |
| Cingulate Inc. | 3.08 Million USD | 12063.832% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -12457.269% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 5231.585% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -249.441% |
| Clearmind Medicine Inc. | -3.94 Million USD | -9254.323% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 4019.726% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 25393.201% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -579.753% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 2234.547% |
| ImmunityBio, Inc. | 618.22 Million USD | 159.656% |
| Korro Bio, Inc. | -132.94 Million USD | -177.417% |
| Kineta, Inc. | -4.54 Million USD | -8021.713% |
| BioVie Inc. | -17.73 Million USD | -1979.854% |
| Codexis, Inc. | -43.27 Million USD | -752.319% |
| Celularity Inc. | 65.19 Million USD | 665.742% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 597.581% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -11537.962% |
| Virax Biolabs Group Limited | -3.36 Million USD | -10860.272% |
| Cibus, Inc. | -8.07 Million USD | -4465.573% |
| IN8bio, Inc. | -16.38 Million USD | -2150.333% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 1024563.889% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -10398.349% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 134.982% |
| Eyenovia, Inc. | 1.25 Million USD | 29400.581% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1470.775% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -11272.402% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1829.109% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -1009.294% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1790.736% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -526.424% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1679.355% |
| Moolec Science SA | 117.61 Thousand USD | 313668.732% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -860.46% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -872.644% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -160.787% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1539.507% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -5176.644% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -6777.059% |
| Humacyte, Inc. | -22.48 Million USD | -1540.163% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1361.085% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -20584.633% |
| Genelux Corporation | -6.89 Million USD | -5245.804% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -1087.44% |
| Notable Labs, Ltd. | -9.77 Million USD | -3672.576% |
| Immunovant, Inc. | -635.22 Million USD | 41.941% |
| Quantum-Si incorporated | -118.55 Million USD | -211.08% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -8801.931% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 4694.581% |
| Acasti Pharma Inc. | -23 Million USD | -1503.16% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -10852.834% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -117.871% |
| PepGen Inc. | -60.67 Million USD | -507.89% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1828.302% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -42680.618% |
| Immuneering Corporation | -54.94 Million USD | -571.256% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8673.833% |
| Belite Bio, Inc | -87.27 Million USD | -322.6% |
| XOMA Corporation | -29 Million USD | -1171.748% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -421.673% |
| Bionomics Limited | 227 Million USD | 262.463% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -14460.087% |
| uniQure N.V. | -102.95 Million USD | -258.235% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8754.0% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 1000.606% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2983.413% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -11819.301% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 348031.132% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -11272.402% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4241.572% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -4873.126% |
| Altimmune, Inc. | -134.48 Million USD | -174.232% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -98.819% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -14460.087% |
| Peak Bio, Inc. | 10.34 Million USD | 3666.744% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -130220.495% |
| Benitec Biopharma Inc. | -50.58 Million USD | -629.127% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -253.473% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1977.358% |
| Zura Bio Limited | -99.8 Million USD | -269.524% |
| PolyPid Ltd. | 6.17 Million USD | 6077.423% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1977.358% |
| argenx SE | -2.02 Billion USD | 81.822% |
| Immunome, Inc. | -97.02 Million USD | -280.1% |
| Verona Pharma plc | -220.44 Million USD | -67.303% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -414.067% |
| Shattuck Labs, Inc. | -121.42 Million USD | -203.735% |
| CervoMed Inc. | -7.79 Million USD | -4632.636% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -8333.73% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -179.951% |
| Moolec Science SA | 117.61 Thousand USD | 313668.732% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -16019.349% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1931.994% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -424.015% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 3383.538% |
| Achilles Therapeutics plc | -126.92 Million USD | -190.573% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 25393.201% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -4857.083% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 208.41% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1653.853% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 17.58% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -162.85% |
| Beam Therapeutics Inc. | -262.72 Million USD | -40.379% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1790.534% |
| AEON Biopharma, Inc. | -4.88 Million USD | -7457.52% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -560.187% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -269.324% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -15608.668% |
| NeurAxis, Inc. | 145.7 Thousand USD | 253227.66% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -845.029% |
| Lumos Pharma, Inc. | -28.49 Million USD | -1194.378% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1675.345% |
| Palisade Bio, Inc. | -12.06 Million USD | -2957.341% |
| Nutriband Inc. | -251.65 Thousand USD | -146451.457% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -342.841% |
| Neurogene Inc. | -131.95 Million USD | -179.495% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -7412.874% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 2.223% |
| Athira Pharma, Inc. | -88.99 Million USD | -314.395% |
| HCW Biologics Inc. | 2.85 Million USD | 13010.355% |
| XOMA Corporation | -29 Million USD | -1171.748% |
| Nektar Therapeutics | 210.24 Million USD | 275.422% |
| Arvinas, Inc. | -313.8 Million USD | -17.529% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 22825.323% |
| Merus N.V. | -192.88 Million USD | -91.207% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 714.832% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -5215.754% |
| Rezolute, Inc. | -68.16 Million USD | -441.027% |
| Clene Inc. | 3.34 Million USD | 11142.126% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2696.747% |
| BeyondSpring Inc. | -13.75 Million USD | -2581.258% |
| Synlogic, Inc. | -6.68 Million USD | -5416.933% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 32622.663% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -4261.999% |
| Peak Bio, Inc. | 10.34 Million USD | 3666.744% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -347.473% |
| Krystal Biotech, Inc. | -350.23 Million USD | -5.303% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 397.125% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -118.234% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -11581.665% |
| MannKind Corporation | 143.89 Million USD | 356.296% |
| Ikena Oncology, Inc. | -109.15 Million USD | -237.871% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -4771.312% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -1014.221% |
| Gossamer Bio, Inc. | 180.35 Million USD | 304.489% |
| CohBar, Inc. | -5.93 Million USD | -6118.576% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -1139.771% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 8177.245% |
| Legend Biotech Corporation | -949.39 Million USD | 61.154% |
| Mural Oncology plc | -255.84 Million USD | -44.154% |
| Disc Medicine, Inc. | -358.28 Million USD | -2.938% |
| Champions Oncology, Inc. | 4.81 Million USD | 7764.318% |
| REGENXBIO Inc. | 54.76 Million USD | 773.399% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -137050.39% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -144.204% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3992.396% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -357.106% |
| Vaxart, Inc. | -8.24 Million USD | -4375.27% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -634.969% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -190.021% |
| Cellectis S.A. | -43.85 Million USD | -740.969% |
| Longeveron Inc. | -2.9 Million USD | -12582.497% |
| Repare Therapeutics Inc. | -107.85 Million USD | -241.938% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 138.085% |
| Inozyme Pharma, Inc. | 12 Million USD | 3172.368% |
| Revolution Medicines, Inc. | -608.2 Million USD | 39.361% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -29884.309% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -39.111% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -145.753% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -2257.046% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -49738.784% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.144% |
| Denali Therapeutics Inc. | -74.86 Million USD | -392.629% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2975.519% |
| Veru Inc. | 4.77 Million USD | 7815.678% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -3179.45% |
| Cingulate Inc. | 3.08 Million USD | 12063.832% |
| Passage Bio, Inc. | 4.58 Million USD | 8143.773% |
| Context Therapeutics Inc. | -14.44 Million USD | -2452.328% |
| Exicure, Inc. | 5.84 Million USD | 6405.471% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -60.089% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -832.037% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 2450.437% |
| Nuvalent, Inc. | -335.38 Million USD | -9.965% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 21364.965% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -395.163% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -4048.56% |
| OmniAb, Inc. | 9.2 Million USD | 4107.465% |
| Anew Medical, Inc. | 1.43 Million USD | 25846.318% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 2351.328% |
| Lipocine Inc. | -4.75 Million USD | -7656.859% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -235.804% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2521.423% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -628.019% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1581.629% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -5387.383% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -460.267% |
| Ocugen, Inc. | -32.52 Million USD | -1034.058% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -330.975% |
| Q32 Bio Inc. | -37.94 Million USD | -871.875% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -58627.229% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2626.048% |
| Equillium, Inc. | -22.39 Million USD | -1547.048% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1342.455% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -1030.382% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -148663.487% |
| Dominari Holdings Inc. | 195 Thousand USD | 189231.795% |
| Edesa Biotech, Inc. | -5.26 Million USD | -6902.341% |
| vTv Therapeutics Inc. | -8.91 Million USD | -4035.999% |
| Bio-Techne Corporation | 267.74 Million USD | 237.745% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -2175.322% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -212.3% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -4288.992% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2815.24% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -50.46% |
| Nkarta, Inc. | 57.29 Million USD | 743.653% |
| BioCardia, Inc. | 212 Thousand USD | 174065.566% |
| Iterum Therapeutics plc | 13.43 Million USD | 2844.508% |